๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO ยท Real-Time Price ยท USD
0.4205
-0.0026 (-0.61%)
At close: Nov 18, 2026, 4:00 PM EST
0.4500
+0.0295 (7.02%)
After-hours: Nov 18, 2026, 7:30 PM EST

Telomir Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-5.69-10.54-12.24-3.94-0.85-0.14
Net Income
-51.59-10.41-16.53-13.07-0.85-0.14
Earnings Per Share
-1.04-0.33-0.56-0.48-0.03-
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
4.527.291.27000
Total Debt
0.070.470.090.630.580.12
Net Cash (Debt)
4.456.811.17-0.63-0.58-0.12
Net Cash Growth
-38.54%480.96%----
Net Cash Per Share
0.090.220.04-0.02-0.02-

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-4.57-3.69-5.07-3.86-0.47-0.12
Free Cash Flow
-4.57-3.69-5.07-3.86-0.47-0.12
Free Cash Flow Growth
------

Valuation

Selected indicators aren't available for this stock.